“Given the segment's strength in the quarter, it is not hard to see a pathway to $1 billion in annual earnings over the near term.”

In context

“ng full-year adjusted earnings ex notables to $1.7 billion. For the year, RIS benefited from record origination in both PRT and UK longevity reinsurance. For Asia, adjusted earnings ex notable totaled $444 million for the quarter, and $1.6 billion for the year. Strong annual sales growth from new products, in particular, foreign currency-denominated products, in Japan and Korea, pushed general account assets under management to advance 7% on a constant currency basis in 2025. John McCallion: Looking to Latin America, adjusted earnings excluding notable items came to $227 million, up 13% in the quarter. Business momentum in the region has been outstanding over the past several years, supplemented by the expansion of digital platforms such as Accelerator, and growing strategic partnerships. Given the segment's strength in the quarter, it is not hard to see a pathway to $1 billion in annual earnings over the near term. With EMEA, the segment continues to punch above its weight class relative to last year's outlook. The segment reported adjusted earnings ex notables of $97 million in the quarter, which is close to the run rate implied by our 2026 outlook. And to close out business highlights, in the fourth quarter, we transitioned to new segmentation with the introduction of MetLife Investment Management as a business segment. This aligns with our New Frontier strategic priorities, reflects the critical mass we've gained with the acquisition of PineBridge, and underscores our intent to grow and further capitalize on the increasing convergence of life insurance and asset management. Moving to cash and capital. The fourth quarter serves as an excellent reminder of MetLife's capital strength and flexibility”